Clinical Trials Browser

Phase 1/2 × monalizumab × Tumor-Agnostic × Clear all

NCT02671435 2025-07-22

A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors

Phase 1/2 Active not recruiting

383 enrolled 48 charts

Neoplasm Metastasis